Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Biological Effects of 5-Azacitidine Five Days/Monthly Schedule in Symptomatic Low-risk Myelodysplastic Syndromes (MDSs)

NCT00897130 is registered in ClinicalTrials.gov with Università degli Studi di Brescia as lead sponsor.

NCT NCT00897130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Biological Effects of 5-Azacitidine Five Days/Monthly Schedule in Symptomatic Low-risk Myelodysplastic Syndromes (MDSs)
Lead sponsor
Università degli Studi di Brescia
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2008
Completion date
December 31, 2014
Enrollment
28 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome